Cardio-Ankle Vascular Index Reflects Impaired Exercise Capacity and Predicts Adverse Prognosis in Patients With Heart Failure. 2021

Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Aims: We aimed to assess the associations of CAVI with exercise capacity in heart failure (HF) patients. In addition, we further examined their prognosis. Methods: We collected the clinical data of 223 patients who had been hospitalized for decompensated HF and had undergone both CAVI and cardiopulmonary exercise testing. Results: For the prediction of an impaired peak oxygen uptake (VO2) of < 14 mL/kg/min, receiver-operating characteristic curve demonstrated that the cutoff value of CAVI was 8.9. In the multivariate logistic regression analysis for predicting impaired peak VO2, high CAVI was found to be an independent factor (odds ratio 2.343, P = 0.045). We divided these patients based on CAVI: the low-CAVI group (CAVI < 8.9, n = 145) and the high-CAVI group (CAVI ≥ 8.9, n = 78). Patient characteristics and post-discharge cardiac events were compared between the two groups. The high-CAVI group was older (69.0 vs. 58.0 years old, P < 0.001) and had lower body mass index (23.0 vs. 24.1 kg/m2, P = 0.013). During the post-discharge follow-up period of median 1,623 days, 58 cardiac events occurred. The Kaplan-Meier analysis demonstrated that the cardiac event rate was higher in the high-CAVI group than in the low-CAVI group (log-rank P = 0.004). The multivariate Cox proportional hazard analysis revealed that high CAVI was an independent predictor of cardiac events (hazard ratio 1.845, P = 0.035). Conclusion: High CAVI is independently associated with impaired exercise capacity and a high cardiac event rate in HF patients.

UI MeSH Term Description Entries

Related Publications

Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
January 2022, International heart journal,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
November 2020, Heart and vessels,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
July 2020, International heart journal,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
November 2011, Journal of cardiac failure,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
June 2023, Journal of the American Heart Association,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
January 2018, Vascular health and risk management,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
December 2020, European journal of preventive cardiology,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
January 2015, Hypertension research : official journal of the Japanese Society of Hypertension,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
August 2017, Medical science monitor : international medical journal of experimental and clinical research,
Koichiro Watanabe, and Akiomi Yoshihisa, and Yu Sato, and Yu Hotsuki, and Fumiya Anzai, and Yasuhiro Ichijo, and Yusuke Kimishima, and Tetsuro Yokokawa, and Tomofumi Misaka, and Takamasa Sato, and Takashi Kaneshiro, and Masayoshi Oikawa, and Atsushi Kobayashi, and Yasuchika Takeishi
September 2016, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!